BB Biotech AG

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
BB Biotech AG
CIK #0000924223
Sector Form 13F Holdings Value ($B)
Argenx SE 0.3
ISIS Pharmaceuticals Inc 0.3
Neurocrine Biosciences Inc 0.2
Alnylam Pharmaceuticals Inc 0.2
Abbott Laboratories 0.2
Stryker Corp 0.2
Intuitive Surgical Inc 0.2
Vertex Pharmaceuticals Inc / Ma 0.2
Boston Scientific Corp 0.2
Revolution Medicines Inc 0.2
View All
Holdings by Sector ($B)
151296302012201620212026
EDGAR Form CIK 2011 - 2025
13F-HR [0000924223]
13F-NT [0000924223]
3 [0000924223]
4 [0000924223]
SC 13G [0000924223]
Form 13D/13G Filer Form 13D/13G Subject Filed
BB Biotech AG Annexon Inc [2024-04-22]
BB Biotech AG Sage Therapeutics Inc [2023-02-17]
BB Biotech AG Revolution Medicines Inc [2022-09-30]
BB Biotech AG Mersana Therapeutics Inc [2021-09-16]
BB Biotech AG Sage Therapeutics Inc [2021-08-11]
BB Biotech AG ESSA Pharma Inc [2021-05-05]
BB Biotech AG Black Diamond Therapeutics Inc [2021-02-11]
BB Biotech AG Generation Bio Co [2021-01-08]
BB Biotech AG Intra-Cellular Therapies Inc [2020-02-06]
BB Biotech AG Molecular Templates Inc [2020-01-29]
View All
Form 3/4/5 Subject 2011 - 2025
Biotech Growth N V
Black Diamond Therapeutics, Inc.
BB Biotech AG
Biotech Target N V
Molecular Templates, Inc.
ESSA Pharma Inc.
Macrogenics Inc
Radius Health, Inc.
Esperion Therapeutics, Inc.
Cidara Therapeutics, Inc.
Terms | Privacy | Guide
tony@aum13f.com